Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Shanghai Pharmaceuticals Holding Co., Ltd SHPMY

Set alert

Price alert · SHPMY

All alert types
7.09 USD 0.00 0.00%

At close · Oct 30

6.45 Day range 6.45
6.41 52-week range 8.23
YTD
-13.85%
1 year
-13.85%
Open
6.45
Prev close
7.09
Mkt cap
5.26B
Vol
1
Avg vol
70
EPS
0.92
P/E
7.71
More statistics
Low
6.45
High
6.45

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SHPMY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.01 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 5
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 4
  • P/B 5

Valuation

P/E 7.5×
FY 2016: 15.5×FY 2017: 12.6×FY 2018: 13.0×FY 2019: 9.5×FY 2020: 6.9×FY 2021: 6.7×FY 2022: 7.0×FY 2023: 10.2×FY 2024: 9.9×FY 2025: 7.5×
FY 2016 5y median 7.5× FY 2025
P/S 0.2×
FY 2016: 0.4×FY 2017: 0.3×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
P/B 0.6×
FY 2016: 1.6×FY 2017: 1.3×FY 2018: 1.3×FY 2019: 0.9×FY 2020: 0.7×FY 2021: 0.7×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.6×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
P/FCF 11.2×
FY 2016: -288×FY 2017: 68.9×FY 2018: 42.2×FY 2019: 11.9×FY 2020: 8.1×FY 2021: 36.4×FY 2022: 19.0×FY 2023: 17.0×FY 2024: 13.2×FY 2025: 11.2×
FY 2016 5y median 17.0× FY 2025
EV/EBITDA 4.1×
FY 2016: 9.2×FY 2017: 7.2×FY 2018: 9.4×FY 2019: 5.9×FY 2020: 4.1×FY 2021: 3.9×FY 2022: 4.0×FY 2023: 4.7×FY 2024: 4.7×FY 2025: 4.1×
FY 2016 5y median 4.1× FY 2025
EV/Sales 0.2×
FY 2016: 0.4×FY 2017: 0.4×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
FCF Yield 8.9%
FY 2016: -0.3%FY 2017: 1.5%FY 2018: 2.4%FY 2019: 8.4%FY 2020: 12.4%FY 2021: 2.7%FY 2022: 5.3%FY 2023: 5.9%FY 2024: 7.6%FY 2025: 8.9%
FY 2016 5y median 5.9% FY 2025

Profitability

Gross Margin 10.7%
FY 2016: 11.8%FY 2017: 12.8%FY 2018: 14.2%FY 2019: 14.4%FY 2020: 14.3%FY 2021: 13.2%FY 2022: 13.1%FY 2023: 12.0%FY 2024: 11.1%FY 2025: 10.7%
FY 2016 5y median 12.0% FY 2025
Operating Margin 3.5%
FY 2016: 3.5%FY 2017: 4.0%FY 2018: 3.3%FY 2019: 4.8%FY 2020: 3.7%FY 2021: 3.8%FY 2022: 3.9%FY 2023: 2.9%FY 2024: 3.0%FY 2025: 3.5%
FY 2016 5y median 3.5% FY 2025
Net Margin 2.0%
FY 2016: 2.6%FY 2017: 2.7%FY 2018: 2.4%FY 2019: 2.2%FY 2020: 2.3%FY 2021: 2.4%FY 2022: 2.4%FY 2023: 1.4%FY 2024: 1.7%FY 2025: 2.0%
FY 2016 5y median 2.0% FY 2025
ROE 7.5%
FY 2016: 10.1%FY 2017: 10.3%FY 2018: 9.9%FY 2019: 9.8%FY 2020: 9.9%FY 2021: 10.3%FY 2022: 8.4%FY 2023: 5.5%FY 2024: 6.4%FY 2025: 7.5%
FY 2016 5y median 7.5% FY 2025
ROIC 5.0%
FY 2016: 6.7%FY 2017: 7.0%FY 2018: 5.6%FY 2019: 7.3%FY 2020: 5.6%FY 2021: 5.9%FY 2022: 6.2%FY 2023: 4.5%FY 2024: 4.5%FY 2025: 5.0%
FY 2016 5y median 5.0% FY 2025
ROA 2.5%
FY 2016: 3.9%FY 2017: 3.7%FY 2018: 3.1%FY 2019: 3.0%FY 2020: 3.0%FY 2021: 3.1%FY 2022: 2.8%FY 2023: 1.8%FY 2024: 2.1%FY 2025: 2.5%
FY 2016 5y median 2.5% FY 2025

Growth (YoY)

Revenue 3.0%
FY 2016: 14.5%FY 2017: 8.3%FY 2018: 21.6%FY 2019: 17.3%FY 2020: 2.9%FY 2021: 12.5%FY 2022: 7.5%FY 2023: 12.2%FY 2024: 5.7%FY 2025: 3.0%
FY 2016 FY 2025
Operating Income 22.1%
FY 2016: 14.1%FY 2017: 24.3%FY 2018: -0.4%FY 2019: 71.4%FY 2020: -19.5%FY 2021: 14.2%FY 2022: 9.9%FY 2023: -14.9%FY 2024: 6.2%FY 2025: 22.1%
FY 2016 FY 2025
EPS (diluted) 25.2%
FY 2016: 11.2%FY 2017: 10.1%FY 2018: 4.6%FY 2019: 5.1%FY 2020: 9.7%FY 2021: 13.3%FY 2022: -10.1%FY 2023: -36.6%FY 2024: 20.6%FY 2025: 25.2%
FY 2016 FY 2025
Free Cash Flow 11.7%
FY 2016: 53.5%FY 2017: 471.7%FY 2018: 85.8%FY 2019: 174.3%FY 2020: 17.3%FY 2021: -75.4%FY 2022: 118.4%FY 2023: 9.8%FY 2024: 51.5%FY 2025: 11.7%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 1.5×FY 2017: 1.4×FY 2018: 1.4×FY 2019: 1.3×FY 2020: 1.2×FY 2021: 1.3×FY 2022: 1.4×FY 2023: 1.3×FY 2024: 1.4×FY 2025: 1.3×
FY 2016 5y median 1.3× FY 2025
Quick Ratio 1.0×
FY 2016: 1.1×FY 2017: 1.0×FY 2018: 1.0×FY 2019: 1.0×FY 2020: 0.9×FY 2021: 1.0×FY 2022: 1.0×FY 2023: 1.0×FY 2024: 1.1×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 0.7×
FY 2016: 0.4×FY 2017: 0.5×FY 2018: 0.8×FY 2019: 0.8×FY 2020: 0.7×FY 2021: 0.6×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.7×FY 2025: 0.7×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA 1.2×
FY 2016: 0.1×FY 2017: 0.3×FY 2018: 1.9×FY 2019: 1.7×FY 2020: 1.0×FY 2021: 0.8×FY 2022: 0.9×FY 2023: 1.1×FY 2024: 1.0×FY 2025: 1.2×
FY 2016 5y median 1.0× FY 2025
Interest Coverage 5.9×
FY 2016: 6.5×FY 2017: 6.0×FY 2018: 4.3×FY 2019: 6.4×FY 2020: 5.1×FY 2021: 5.4×FY 2022: 5.3×FY 2023: 4.6×FY 2024: 5.0×FY 2025: 5.9×
FY 2016 5y median 5.3× FY 2025

Dividends

Dividend Yield 6.5%
FY 2016: 2.9%FY 2017: 4.0%FY 2018: 4.7%FY 2019: 3.0%FY 2020: 4.0%FY 2021: 4.0%FY 2022: 4.0%FY 2023: 10.3%FY 2024: 8.0%FY 2025: 6.5%
FY 2016 5y median 6.5% FY 2025
Payout Ratio 48.9%
FY 2016: 45.2%FY 2017: 49.7%FY 2018: 60.8%FY 2019: 28.6%FY 2020: 27.8%FY 2021: 26.8%FY 2022: 27.6%FY 2023: 105.7%FY 2024: 79.2%FY 2025: 48.9%
FY 2016 5y median 48.9% FY 2025

Annual · latest fiscal year ends 2025-12-31